CoChat

The Use of Intravenous Immunoglobulin in Recurrent Pregnancy Loss Associated With Combined Alloimmune and Autoimmune Abnormalities

Kiprov, Dobri D., Nachtigall, Robert D., Weaver, Roderic C., Jacobson, Arnold, Main, Elliott K., Garovoy, Marvin R. · 1996 · American Journal of Reproductive Immunology
Cited by 88

The DOI matches its Crossref record.

Abstract

PROBLEM: Several studies have evaluated the effect of intravenous gammaglobulin (IVIG) in women with unexplained recurrent spontaneous abortions (RSA). Data regarding the underlying immunologic abnormalities in these patients is scant. This study reports the pregnancy outcome and immunologic changes observed in a large group of women with RSA associated with well‐defined alloimmune and autoimmune abnormalities treated with IVIG. METHODS: Thirty‐five patients with three or more recurrent miscarriages were studied. None of the patients had identifiable alloimmune response to paternal lymphocytes. Twenty‐four patients had anti‐thyroid antibodies, ten patients had high levels of circulating immune complexes, and six patients had anti‐cardiolipin antibodies. Five patients had Hashimoto's disease, one had immune thrombocytopenic purpura, and one had Crohn's disease. Twenty‐three patients had more than one autoimmune abnormality. All patients received IVIG infusions (200–250 mg/kg) every 3 weeks during the first 8 months of pregnancy. RESULTS: Twenty‐eight patients (80%) had a successful pregnancy. Decrease of the level of autoantibodies and circulating immune complexes was observed in all patients who had a successful pregnancy. Only three of these patients developed measurable alloimmune response to paternal antigens. CONCLUSIONS: This preliminary study suggests that IVIG may be of benefit to patients with recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. This benefit was seen in spite of lack of detectable correction of the alloimmune abnormality in the majority of patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-0897.1996.tb00168.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 88

Metadata

Authors
Kiprov, D. D., Nachtigall, R. D., Weaver, R. C., Jacobson, A., Main, E. K., & Garovoy, M. R.
Venue
American Journal of Reproductive Immunology
Publisher
Wiley
Published
1996-10
Volume
36
Issue
4
Pages
228-234
ISSN
  • 0271-7352 (ISSN-L)
  • 1046-7408
  • 1600-0897
OpenAlex
W2013694468
Cited by
88
References
0
FWCI
1.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Use of Intravenous Immunoglobulin in Recurrent Pregnancy Loss Associated With Combined Alloimmune and Autoimmune Abnormalities. https://app.cochat.ai/papers/10.1111/j.1600-0897.1996.tb00168.x
The paper
Kiprov, D. D., Nachtigall, R. D., Weaver, R. C., Jacobson, A., Main, E. K., & Garovoy, M. R. (1996). The Use of Intravenous Immunoglobulin in Recurrent Pregnancy Loss Associated With Combined Alloimmune and Autoimmune Abnormalities. American Journal of Reproductive Immunology. https://doi.org/10.1111/j.1600-0897.1996.tb00168.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.